Download
s00109-020-01966-z.pdf 568,80KB
WeightNameValue
1000 Titel
  • Need for a precise molecular diagnosis in Beckwith-Wiedemann and Silver-Russell syndrome: what has to be considered and why it is important
1000 Autor/in
  1. Eggermann, Thomas |
  2. Brück, Johanna |
  3. Knopp, Cordula |
  4. Fekete, György |
  5. Kratz, Christian |
  6. Tasic, Velibor |
  7. Kurth, Ingo |
  8. Elbracht, Miriam |
  9. Eggermann, Katja |
  10. Begemann, Matthias |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-08-24
1000 Erschienen in
1000 Quellenangabe
  • 98(10):1447-1455
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00109-020-01966-z |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524824/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Molecular diagnostic testing of the 11p15.5-associated imprinting disorders Silver-Russell and Beckwith-Wiedemann syndrome (SRS, BWS) is challenging due to the broad spectrum of molecular defects and their mosaic occurrence. Additionally, the decision on the molecular testing algorithm is hindered by their clinical heterogeneity. However, the precise identification of the type of defect is often a prerequisite for the clinical management and genetic counselling. Four major molecular alterations (epimutations, uniparental disomies, copy number variants, single nucleotide variants) have been identified, but their frequencies vary between SRS and BWS. Due to their molecular aetiology, epimutations in both disorders as well as upd(11)pat in BWS are particular prone to mosaicism which might additionally complicate the interpretation of testing results. We report on our experience of molecular analysis in a total cohort of 1448 patients referred for diagnostic testing of BWS and SRS, comprising a dataset from 737 new patients and from 711 cases from a recent study. Though the majority of positively tested patients showed the expected molecular results, we identified a considerable number of clinically unexpected molecular alterations as well as not yet reported changes and discrepant mosaic distributions. Additionally, the rate of multilocus imprinting disturbances among the patients with epimutations and uniparental diploidies could be further specified. Altogether, these cases show that comprehensive testing strategies have to be applied in diagnostic testing of SRS and BWS. The precise molecular diagnosis is required as the basis for a targeted management (e.g. ECG (electrocardiogram) and tumour surveillance in BWS, growth treatment in SRS). The molecular diagnosis furthermore provides the basis for genetic counselling. However, it has to be considered that recurrence risk calculation is determined by the phenotypic consequences of each molecular alteration and mechanism by which the alteration arose. KEY MESSAGES: The detection rates for the typical molecular defects of Beckwith-Wiedemann syndrome or Silver-Russell syndrome (BWS, SRS) are lower in routine cohorts than in clinically well-characterised ones. A broad spectrum of (unexpected) molecular alterations in both disorders can be identified. Multilocus imprinting disturbances (MLID) are less frequent in SRS than expected. The frequency of MLID and uniparental diploidy in BWS is confirmed. Mosaicism is a diagnostic challenge in BWS and SRS. The precise determination of the molecular defects affecting is the basis for a targeted clinical management and genetic counselling.
1000 Sacherschließung
lokal Genetic Association Studies/methods [MeSH]
lokal Genetic Predisposition to Disease [MeSH]
lokal Silver-Russell Syndrome/genetics [MeSH]
lokal Female [MeSH]
lokal Silver-Russell syndrome
lokal Humans [MeSH]
lokal Precision Medicine/methods [MeSH]
lokal Beckwith-Wiedemann Syndrome/genetics [MeSH]
lokal Diagnostics
lokal Beckwith-Wiedemann Syndrome/diagnosis [MeSH]
lokal Silver-Russell Syndrome/diagnosis [MeSH]
lokal Cohort Studies [MeSH]
lokal Original Article
lokal Genetic Testing/standards [MeSH]
lokal Pedigree [MeSH]
lokal Male [MeSH]
lokal Detection rate
lokal Genetic Association Studies/standards [MeSH]
lokal Genomic Imprinting [MeSH]
lokal MS MLPA
lokal Genetic Testing/methods [MeSH]
lokal Beckwith-Wiedemann syndrome
lokal Precision Medicine/standards [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-8419-0264|https://frl.publisso.de/adhoc/uri/QnLDvGNrLCBKb2hhbm5h|https://frl.publisso.de/adhoc/uri/S25vcHAsIENvcmR1bGE=|https://frl.publisso.de/adhoc/uri/RmVrZXRlLCBHecO2cmd5|https://frl.publisso.de/adhoc/uri/S3JhdHosIENocmlzdGlhbg==|https://frl.publisso.de/adhoc/uri/VGFzaWMsIFZlbGlib3I=|https://frl.publisso.de/adhoc/uri/S3VydGgsIEluZ28=|https://frl.publisso.de/adhoc/uri/RWxicmFjaHQsIE1pcmlhbQ==|https://frl.publisso.de/adhoc/uri/RWdnZXJtYW5uLCBLYXRqYQ==|https://frl.publisso.de/adhoc/uri/QmVnZW1hbm4sIE1hdHRoaWFz
1000 Hinweis
  • DeepGreen-ID: 8bd3252c00f14f66b76137c68385fe86 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6443076.rdf
1000 Erstellt am 2023-04-26T17:04:15.478+0200
1000 Erstellt von 322
1000 beschreibt frl:6443076
1000 Zuletzt bearbeitet 2023-10-19T13:57:31.590+0200
1000 Objekt bearb. Thu Oct 19 13:57:31 CEST 2023
1000 Vgl. frl:6443076
1000 Oai Id
  1. oai:frl.publisso.de:frl:6443076 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source